China Universal Asset Management Company’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.05M Sell
76,302
-1,013
-1% -$76.2K 0.36% 56
2026
Q1
$5.81M Buy
77,315
+34,921
+82% +$2.76M 0.44% 52
2025
Q4
$3.35M Buy
42,394
+14,455
+52% +$1.09M 0.26% 71
2025
Q3
$1.83M Sell
27,939
-4,027
-13% -$197K 0.15% 120
2025
Q2
$1.26M Buy
31,966
+80
+0.3% +$2.62K 0.12% 148
2025
Q1
$962K Sell
31,886
-1,594
-5% -$52.2K 0.09% 190
2024
Q4
$1.17M Buy
33,480
+5,359
+19% +$200K 0.11% 142
2024
Q3
$1.13M Buy
28,121
+10,971
+64% +$510K 0.12% 131
2024
Q2
$817K Sell
17,150
-10,877
-39% -$446K 0.12% 115
2024
Q1
$1.21M Buy
28,027
+11,429
+69% +$545K 0.15% 112
2023
Q4
$840K Buy
16,598
+12,928
+352% +$619K 0.16% 119
2023
Q3
$166K Buy
3,670
+1,795
+96% +$74.1K 0.05% 158
2023
Q2
$76.9K Sell
1,875
-62
-3% -$2.38K 0.02% 165
2023
Q1
$69.2K Buy
1,937
+494
+34% +$18.6K 0.02% 142
2022
Q4
$54.5K Buy
1,443
+114
+9% +$4.79K 0.02% 135
2022
Q3
$59K Buy
+1,329
New +$56K 0.02% 120

Other funds holding IONS

China Universal Asset Management Company's IONS Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Ionis Pharmaceuticals (IONS) stake by 1.3% in Q2 2026, selling an estimated $76.2K and leaving 76,302 shares worth $6.05M. The position accounts for 0.36% of the portfolio, ranked #56.

China Universal Asset Management Company first reported a position in IONS in Q3 2022 and has held it in 16 quarters since. 84 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • China Universal Asset Management Company held 76,302 shares of Ionis Pharmaceuticals worth $6.05M as of Q2 2026.
  • China Universal Asset Management Company sold 1,013 Ionis Pharmaceuticals shares in Q2 2026, an estimated $76.2K.
  • Ionis Pharmaceuticals made up 0.36% of China Universal Asset Management Company's portfolio in Q2 2026, its #56 holding.
  • China Universal Asset Management Company first reported a position in Ionis Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
  • 84 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.